Clarification of dalfampridine labeled indications
J Manag Care Pharm
.
2012 Mar;18(2):156.
doi: 10.18553/jmcp.2012.18.2.156.
Authors
Adrian L Rabinowicz
,
Enrique J Carrazana
PMID:
22380474
PMCID:
PMC10437778
DOI:
10.18553/jmcp.2012.18.2.156
No abstract available
Publication types
Letter
Comment
MeSH terms
Consensus*
Humans
Multiple Sclerosis / drug therapy*
Pharmacy Service, Hospital / standards*